HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas.

Abstract
p27kip1 is a cyclin-dependent kinase inhibitor that regulates progression from G1 into S phase. Aberrations in cell cycle control are often observed in tumors and might even be necessary in tumor development. Recent reports showed that low p27kip1 expression is associated with poor prognosis in several tumors and leukemia. To investigate the expression of p27kip1 in malignant lymphomas and elucidate the role of p27kip1 as a possible prognostic indicator, the authors performed an immunohistochemical staining of p27kip1 correlated with Ki-67 labelling index and clinical parameters. p27kip1 expression was reduced variably in most malignant lymphomas and inversely correlated with Ki-67 labelling index (p=0.0151). Regarding chemotherapeutic response, p271kip1 expression in the complete remission group showed statistically significant difference in expression compared to the progressive disease group (p=0.0021). There were significant differences in survival between cases with low and high p27kip1 expression (p=0.0071). In a multivariate Cox analysis, p27kip1 expression was independent prognostic factors as well as other known prognostic factors including age, grade, stage and chemotherapeutic response. In conclusion, the study suggests that reduced expression of p27kip1 protein may play a role in the pathogenesis and biologically aggressive behavior of malignant lymphomas.
AuthorsY H Oh, C K Park
JournalJournal of Korean medical science (J Korean Med Sci) Vol. 15 Issue 4 Pg. 399-406 (Aug 2000) ISSN: 1011-8934 [Print] KOREA (SOUTH)
PMID10983687 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Cell Cycle Proteins
  • Ki-67 Antigen
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • Tumor Suppressor Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
Topics
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cell Cycle
  • Cell Cycle Proteins
  • Cell Division
  • Child
  • Child, Preschool
  • Cyclin-Dependent Kinase Inhibitor p27
  • Female
  • Follow-Up Studies
  • Humans
  • Ki-67 Antigen (analysis)
  • Life Tables
  • Lymphoma, Non-Hodgkin (chemistry, drug therapy, mortality, pathology)
  • Male
  • Microtubule-Associated Proteins (analysis, physiology)
  • Middle Aged
  • Neoplasm Proteins (analysis, physiology)
  • Prognosis
  • Proportional Hazards Models
  • Survival Analysis
  • Treatment Outcome
  • Tumor Suppressor Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: